Finotonlimab (Anti-PDCD1 / PD-1 / CD279)
Finotonlimab (Anti-PDCD1 / PD-1 / CD279) (A2858-GRP)
Products
Description
Finotonlimab (Anti-PDCD1 / PD-1 / CD279) is a recombinant, humanized monoclonal antibody directed against the negative immunoregulatory human cell receptor programmed cell death protein 1 (PD-1, PDCD1, CD279) with potential immune checkpoint inhibitory and antineoplastic activities. MW: 145.38 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2858 |
| Target | PD-1/PD-L1 |